Sunday, 23 June 2013

Yahoo! Finance: Biotechnology Industry News: XTANDI™▼ (Enzalutamide) Authorised in the European Union (EU) for Advanced Prostate Cancer

Yahoo! Finance: Biotechnology Industry News
The latest news on the Biotechnology industry from Yahoo! Finance
XTANDI™▼ (Enzalutamide) Authorised in the European Union (EU) for Advanced Prostate Cancer
Jun 24th 2013, 06:00

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment